Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

PCFCL may have unrecognized subtypes and needs more research.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Topical IKKα inhibitors may help prevent CCS tumours.

CAP1 decreases the expression of a hair-related protein in young Tan sheep's skin.